Crossmark

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters

Crossref DOI link: https://doi.org/10.1038/s41598-022-10281-1

Published Online: 2022-04-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bernard, Marie-Clotilde

Boudet, Florence

Pineda-Peña, Andrea-Clemencia

Guinet-Morlot, Françoise
License Information

Text and Data Mining valid from 2022-04-21

Version of Record valid from 2022-04-21
More Information

Article History

Received: 3 November 2021

Accepted: 30 March 2022

First Online: 21 April 2022

Competing interests

: MCB was an employee of Sanofi at the time of submission of the manuscript. FB, ACPP, and FGM are currently employees of Sanofi. ACPP, MCB, and FB may hold shares in the company.

Document is current

Any future updates will be listed below